NCT02147938View on ClinicalTrials.gov

A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)

CompletedOBSERVATIONAL
Enrollment

578

Participants

Timeline

Start Date

July 17, 2014

Primary Completion Date

May 15, 2017

Study Completion Date

May 15, 2017

Conditions
Renal Transplantation
Interventions
DRUG

Tacrolimus

oral

Trial Locations (26)

Unknown

Site, Amiens

Site, Angers

Site, Besançon

Site, Brest

Site, Caen

Site, Clermond-Ferrand

Site, Créteil

Site, Dijon

Site, Le Krémlin-Bicêtre

Site, Lille

Site, Limoges

Site, Lyon

Site, Marseille

Site, Montpellier

Site, Nancy

Site, Nantes

Site, Nice

Site, Paris

Site, Poitiers

Site, Rennes

Site, Rouen

Site, Saint-Etienne

Site, Strasbourg

Site, Suresnes

Site, Toulouse

Site, Tours

All Listed Sponsors
lead

Astellas Pharma S.A.S.

INDUSTRY

NCT02147938 - A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®) | Biotech Hunter | Biotech Hunter